Boston Scientific
Boston Scientific treats over 37 million patients annually and operates in 40 countries, offering a diverse range of medical specialties and products. The company has been recognized for its innovation, workplace culture, and commitment to sustainability.
About Boston Scientific
Boston Scientific treats over 37 million patients each year and operates globally with locations in 40 countries. The company offers a wide range of medical specialties, including Critical Care, Electrophysiology, Gastroenterology, Interventional Cardiology, Neurological Surgery, and Urology. With a product portfolio that includes over 15,000 products, Boston Scientific has made a substantial impact in the medical field.
Research and Development
Boston Scientific has invested $1.4 billion in research and development to drive innovation and improve patient care. This significant financial commitment is reflected in the company's diverse range of medical devices and technologies aimed at treating complex health conditions.
Medical Education and Training
Boston Scientific provides comprehensive medical education and training through its EDUCARE platform. This initiative aims to enhance the skills and knowledge of healthcare professionals around the world, contributing to better patient outcomes and advancing medical practice standards.
Awards and Recognitions
Boston Scientific has received numerous awards and recognitions. It has been included in Fortune's list of the World's Most Admired Companies for nine consecutive years and recognized by Forbes as one of the Best Employers for Diversity for six consecutive years. Additionally, the company has earned accolades such as the Edison Awards for excellence in Medtech and AI Assisted Medicine, the Prix Galien USA Award for the WATCHMAN™ Left Atrial Appendage Closure Device, and a spot on the Dow Jones Sustainability Index for North America for three consecutive years.
Financial Performance
Boston Scientific generated $14.2 billion in net sales, indicating strong financial performance and market presence. This financial success supports the company's strategic initiatives in research and development, global expansion, and comprehensive medical education programs.